Table 1 Demographic and clinical characteristics of the multiple myeloma patients.
Characteristics | Patients, n (%) |
|---|---|
Sex, male | 103 (53.9) |
Age, years | |
  < 58 | 68 (35.6) |
 58–67 | 66 (34.6) |
 67 ≤  | 57 (29.8) |
R-ISS stage | |
 I | 51 (26.7) |
 II | 100 (52.4) |
 III | 40 (20.9) |
Chemotherapy regimen | |
 VTD | 83 (43.5) |
 VMP | 49 (25.7) |
 Other | 59 (30.9) |
Radiotherapy | 19 (9.9) |
Autologous stem cell transplantation | 101 (52.9) |
Hypercalcemia | 25 (13.1) |
Renal insufficiency | 46 (24.1) |
Anemia | 96 (50.3) |
Bone lesions | 165 (86.4) |
Extramedullary disease | 35 (18.3) |
Metabolic tumor volume (MTV) | |
  < 22.0 cm3 (low) | 87 (45.5) |
 22.0–83.6 cm3 (moderate) | 48 (25.1) |
 83.6 cm3 ≤ (high) | 56 (29.3) |
Unsupervised clustering | |
 A | 87 (45.5) |
 B | 81 (42.4) |
 C | 23 (12.0) |
Supervised clustering | |
 A | 94 (49.2) |
 B | 68 (35.6) |
 C | 29 (15.2) |
Instrument | |
 Discovery LS | 28 (14.7) |
 Discovery STE | 132 (69.1) |
 Discovery MI DR | 31 (16.2) |
